Stocks to watch today: Signature Global, IndusInd Bank, pharma, railway and renewable energy stocks
Investors will track Signature Global’s project expansion, IndusInd Bank’s RBI nod, regulatory developments involving United Spirits, and business updates from pharma, railway and energy firms. Emcure Pharma, Gland Pharma, RITES, NTPC Green Energy and Adani Enterprises remain in focus.
Signature Global has awarded construction contracts worth Rs 920 crore to KEC International Ltd (Rs 460 crore) and NCC (Rs 460 crore), for its premium housing project ‘Sarvam at DXP Estate’, located in Sector 37D, Dwarka Expressway, Gurugram. KEC International Limited will construct 6 residential towers within 36 months, while NCC Limited will construct 5 residential towers within the same timeframe. Together, these 11 towers will comprise 1,798 residential units, with a development area of approximately 5 million sq. ft. The construction work is expected to commence by the end of the third quarter of FY27.
IndusInd Bank has received approval from the Reserve Bank of India (RBI) to set up a wholly owned subsidiary to undertake stockbroking business. The bank has also been permitted to infuse equity capital into the new subsidiary, subject to additional conditions mentioned in the RBI letter, the release added. Shares of IndusInd Bank closed 1.9 per cent higher at ₹1,025 on the BSE.
Pharma firms in focus
Novartis India has terminated its Distribution and Promotion Agreement with Dr Reddy’s Laboratories Ltd, ending a partnership that granted the latter exclusive rights to promote and sell certain products. The termination, effective on September 30, 2026, allows Novartis India to reacquire exclusivity and secure direct market access for these products, marking a strategic shift in its go-to-market approach.
Emcure Pharma informed the exchanges that it has received the Establishment Inspection Report (EIR) following the USFDA inspection of the company’s formulations facility located at Sanand, Ahmedabad. The US drug regulator conducted this inspection from May 06, 2026, to May 15, 2026. Emcure Pharma added that the FDA has classified the inspection status of the said facility as Voluntary Action Indicated (VAI) and accordingly, the inspection stands closed.
AstraZeneca Pharma India has received approval from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India, to import Enhertu (Trastuzumab Deruxtecan) for sale and distribution in India. The approval is for an additional indication of the drug in the treatment of HER2-positive breast cancer, according to its disclosure to the stock exchanges.
Gland Pharma has announced the execution of a strategic Manufacturing and Supply Agreement (MSA) with one of the leading global pharmaceutical companies for the Technology Transfer, Manufacturing and Supply of a portfolio of sterile injectable products for global markets. The partnership establishes Gland Pharma as an integrated end-to-end partner supporting multiple products across various stages of the product lifecycle, including both commercially marketed products and pipeline products under development. The collaboration follows a full-service CDMO model encompassing technology transfer, process development, scale-up, validation, commercial manufacturing, and long-term supply of sterile injectable products.
Railway stocks
RITES Ltd has signed a Memorandum of Understanding with Hindustan Petroleum Corporation Limited to provide end-to-end consultancy services for the development of railway siding infrastructure across HPCL’s facilities. Under the agreement, the PSU railway major will offer consultancy services spanning the entire project lifecycle for railway siding projects, from concept to commissioning. The scope of work includes feasibility studies, final location surveys, preparation of detailed project reports, detailed engineering, project management consultancy, construction supervision, and coordination with Indian Railways to secure statutory approvals.
Neetu Yoshi Limited will commence commercial production at its new manufacturing facility in Haridwar, Uttarakhand, on September 13, 2026. The expansion, funded entirely by Initial Public Offering (IPO) proceeds, is designed to double the company’s manufacturing capabilities. This capacity boost positions the RDSO-certified vendor to capture a larger share of India’s growing demand for railway infrastructure, directly supporting long-term revenue growth for shareholders.
Power & Energy counters
Fujiyama Power Systems Limited (Fujiyama) has commissioned a 2 GW power-electronics manufacturing facility in Ratlam, Madhya Pradesh. The facility will manufacture a wide range of power electronics products, including solar inverters, UPS systems and other related solutions, the company said in an exchange filing on Friday. The Ratlam facility is a key part of the company’s large-scale greenfield manufacturing expansion project aimed at strengthening its integrated manufacturing capabilities across the rooftop solar value chain, it said.
NTPC Green Energy Ltd has emerged as the successful bidder in the e-reverse auction conducted by West Bengal State Electricity Distribution Company Ltd (WBSEDCL) for the development of standalone Battery Energy Storage System (BESS) projects in West Bengal. NTPC Green Energy secured 200 MW/800 MWh of BESS capacity at a discovered tariff of ₹4.35 lakh per MW per month under the tender.
Juniper Green Energy on Friday said it has emerged as the winning bidder for a 230 MW project under the Solar Energy Corporation of India’s 1,000 MW firm-and-dispatchable renewable energy round-the-clock tender. The company secured the capacity at a tariff of 5.26 per unit, a company statement said. The letter of award is expected to be issued within the timelines prescribed under the tender document.
Strategic decisions
NBCC (India) Limited has concluded the e-auction of approximately 2.34 lakh sq ft of commercial built-up space at Bharat Business Park, Sarojini Nagar, New Delhi. The commercial space was sold through an e-auction for a total sale value of approximately ₹1,236 crore.
Gamco Ltd has acquired a further 25.5 per cent stake in Blissara Resorts Private Ltd for Rs 18.21 crore, raising its total equity holding in the resort company to 33.33 per cent. Earlier, in June, it had acquired a 7.83 per cent stake in Bilssara for Rs 5.07 crore. This strategic investment aims to diversify Gamco’s portfolio and tap into long-term growth within the hospitality sector, it said in a disclosure to the stock exchanges.
G R Infraprojects Ltd has emerged as the successful bidder for Rs 91.6 crore for the development, operation, and maintenance of the Multi-Modal Logistics Park (MMLP) in Varanasi, Uttar Pradesh. The project will be executed under Design, Build, Finance, Operate, and Transfer (DBFOT) terms.
Adani Enterprises Ltd has informed the stock exchanges about the incorporation of a new step-down wholly owned subsidiary — AACL Global IFSC Ltd — for Global Treasury Centre activities under IFSCA regulations.
Regulatory action in focus
United Spirits will remain focused as the food safety regulator warned liquor giant Diageo that it misleadingly claimed one of its top-selling whiskies was “matured in American oak casks”, when most of the product had not been matured, a confidential government notice shows. The previously unreported July 20 notice from the Food Safety and Standards Authority of India, reviewed by Reuters, reveals another complaint by the regulator, in addition to an assertion of improper flavouring that prompted the authorities to ban some spirits this month. The FSSAI announced on Sunday that it had prohibited sales of Diageo’s Royal Challenge Whisky made in the state of Madhya Pradesh and some whisky and rum brands made in some Indian states by Diageo and India’s Inbrew for using artificial flavouring, such as whisky and rum flavours, rather than proper ageing and ingredients.
Published on August 10, 2026
